Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201369
Max Phase: Preclinical
Molecular Formula: C32H37F2N3O4S
Molecular Weight: 597.73
Associated Items:
ID: ALA5201369
Max Phase: Preclinical
Molecular Formula: C32H37F2N3O4S
Molecular Weight: 597.73
Associated Items:
Canonical SMILES: CCCCOC(=O)NS(=O)(=O)c1ccc(CCC)cc1-c1cc(F)c(Cn2c(C(C)(C)C)nc3ccccc32)c(F)c1
Standard InChI: InChI=1S/C32H37F2N3O4S/c1-6-8-16-41-31(38)36-42(39,40)29-15-14-21(11-7-2)17-23(29)22-18-25(33)24(26(34)19-22)20-37-28-13-10-9-12-27(28)35-30(37)32(3,4)5/h9-10,12-15,17-19H,6-8,11,16,20H2,1-5H3,(H,36,38)
Standard InChI Key: LQKIBYRAMKDYMO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 597.73 | Molecular Weight (Monoisotopic): 597.2473 | AlogP: 7.49 | #Rotatable Bonds: 10 |
Polar Surface Area: 90.29 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.93 | CX Basic pKa: 5.49 | CX LogP: 7.10 | CX LogD: 8.06 |
Aromatic Rings: 4 | Heavy Atoms: 42 | QED Weighted: 0.19 | Np Likeness Score: -0.98 |
1. Roy T, Petersen NN, Gopalan G, Gising J, Hallberg M, Larhed M.. (2022) 2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands., 66 [PMID:35576659] [10.1016/j.bmc.2022.116804] |
Source(1):